What is the current cd48 antibody market size?

The cd48 antibody market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the cd48 antibody market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

Which regions are leading the cd48 antibody market?

North America and Europe are the leading regions due to high research activities.

Who are the top companies in the cd48 antibody market?

Companies like AbbVie and Johnson & Johnson are key players in the market.

What are the future opportunities in the cd48 antibody market?

Emerging markets and increasing adoption of targeted therapies offer future opportunities.

How does technology impact the cd48 antibody market?

Advances in technology improve development efficiency and reduce costs.

What is the current regulatory landscape for the cd48 antibody market?

Regulatory bodies like FDA and EMA set strict guidelines for market approval.

What is the future outlook for the cd48 antibody market?

The market is expected to grow significantly due to increasing demand for targeted therapies.

cd48 antibody Industry Trends & Competitive Analysis 2033

cd48 antibody by Application (Flow Cytometry, ELISA, Western Blot, Immunoprecipitation, Immunofluorescence, Others), by Types (Monoclonal Antibody, Polyclonal Antibody), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $220 million

CAGR: 9.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $220 million

CAGR: 9.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

cd48 antibody Market Size | CAGR 9.2 Forecast 2033

cd48 antibody Industry Trends & Competitive Analysis 2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $220 million

CAGR: 9.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $220 million

CAGR: 9.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

cd48 antibody Market Overview

The cd48 antibody market refers to the global market for antibodies targeting the CD48 antigen, which plays a crucial role in the immune system. As the cd48 antibody market size is expected to witness significant growth, driven by increasing demand for targeted therapies, the growth outlook and market forecast are of paramount importance for industry stakeholders. The industry expansion is anticipated to be fueled by advancements in technology, evolving regulatory landscapes, and shifting consumer behavior, making it essential to closely monitor the market trends and dynamics.

Loading chart…

The current cd48 antibody market size is approximately $430 million, with a growth forecast of 10.5% CAGR during the forecast period from 2026 to 2033. The market is driven by key forces such as technology shifts, including the development of novel antibody formats and platforms, regulations, such as evolving guidelines for antibody-based therapies, and consumer behavior, including increasing awareness and adoption of targeted therapies. The largest region in the cd48 antibody market is North America, while the fastest-growing region is Asia-Pacific, driven by increasing investments in research and development and expanding healthcare infrastructure. As the market continues to evolve, it is essential for stakeholders to stay informed about the latest trends, opportunities, and challenges shaping the cd48 antibody market.

Report Overview

Report Attribute	Details
Market size value in 2025	220.00 million
Revenue forecast in 2033	444.84 million
Growth rate	CAGR of 9.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sino Biological, Inc.; Cell Signaling Technology, Inc.; Bio-Techne; OriGene Technologies, Inc.; LifeSpan BioSciences, Inc; Abbexa; MyBiosource, Inc.; Biorbyt; Creative Biolabs; GeneTex; Arigo Biolaboratories Corp.; Abcam; RayBiotech, Inc.; Assay Genie
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The cd48 antibody market is poised for significant growth, driven by increasing demand for targeted therapies and advancements in biomedical research. Key dynamics shaping the market include growth drivers, restraints, opportunities, and challenges that collectively influence the cd48 antibody market size and growth forecast.

Growth Drivers2 items

Advances in immunotherapy and cancer research are fueling the adoption of cd48 antibodies, leading to an expansion of the cd48 antibody market.

Government initiatives and funding for biomedical research are providing a boost to the development of cd48 antibodies, contributing to the market's growth forecast.

Restraints2 items

High development costs and stringent regulatory requirements are hindering the growth of the cd48 antibody market, making it challenging for new entrants to compete.

The complexity of antibody engineering and the need for specialized expertise are limiting the supply of high-quality cd48 antibodies, thereby constraining market growth.

Opportunities2 items

The increasing prevalence of cancer and inflammatory diseases is creating a large patient pool, presenting opportunities for the cd48 antibody market to expand its reach and applications.

The growing trend of personalized medicine is driving the demand for targeted therapies, including cd48 antibodies, which are expected to contribute significantly to the cd48 antibody market size.

Challenges2 items

The patent landscape for cd48 antibodies is highly competitive, with several key players holding significant intellectual property rights, making it difficult for new entrants to develop innovative products.

Ensuring the quality and safety of cd48 antibodies while maintaining cost-effectiveness is a major challenge facing manufacturers, which can impact the overall growth forecast of the cd48 antibody market.

Market Segmentation

Loading chart…

The cd48 antibody market can be segmented based on application, which includes research, diagnostics, and therapeutics. The research segment dominates the market due to the increasing use of cd48 antibodies in cancer research and immunology studies. The diagnostics segment is also growing, driven by the demand for cd48 antibodies in flow cytometry and immunohistochemistry. Understanding the cd48 antibody segmentation by application is crucial for market players to identify opportunities and trends.

The cd48 antibody market can also be segmented based on types, which include monoclonal and polyclonal antibodies. Monoclonal antibodies are further divided into subtypes such as murine, humanized, and fully human. Polyclonal antibodies are also divided into subtypes such as rabbit, mouse, and goat. The monoclonal antibodies segment accounts for the largest share of the market due to their high specificity and affinity. The market taxonomy of cd48 antibodies by type is essential for understanding the competitive landscape and market dynamics.

cd48 antibody Segmentation Breakdown10 items

Application

Flow Cytometry

ELISA

Western Blot

Immunoprecipitation

Immunofluorescence

Others

Types

Monoclonal Antibody

Polyclonal Antibody

Regional Insights

Loading chart…

The cd48 antibody market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is expected to be Asia Pacific, driven by increasing adoption of cd48 antibodies in research and development activities. Key drivers for North America include significant investments in biomedical research, a well-established infrastructure, and a mature ecosystem.

In Europe, key drivers include favorable policies supporting biomedical research, a high level of ecosystem maturity, and a large patient population. Asia Pacific's growth is driven by increasing demographics, rising adoption of advanced therapies, and growing investments in research and development. Latin America and Middle East & Africa are expected to witness moderate growth, driven by improving infrastructure and increasing adoption of cd48 antibodies in research applications.

The regional forecast indicates that North America will continue to dominate the market, while Asia Pacific will experience the highest growth rate. Key factors influencing the cd48 antibody market growth include government policies, investments in research and development, and the level of ecosystem maturity. Understanding these regional dynamics is crucial for stakeholders to navigate the cd48 antibody market and capitalize on emerging opportunities.

Competitive Landscape

The cd48 antibody market is moderately consolidated, with a mix of global players and local/regional companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The cd48 antibody competitive landscape is driven by the ability of companies to differentiate themselves through innovative products, strong distribution networks, and strategic partnerships. Key competitive levers include pricing strategies, investment in research and development, and compliance with regulatory requirements.

Companies in the cd48 antibody market employ various strategies to differentiate themselves and gain a competitive edge. These strategies include mergers and acquisitions, partnerships, product launches, expansion into new regions, and investment in research and development. However, companies face challenges such as margin pressure, compliance costs, and commoditization of products. To address these challenges, companies focus on strategic initiatives such as regional expansion, vertical integration, and innovation pipeline development.

Sino Biological, Inc. - Regional expansion

Cell Signaling Technology, Inc. - Innovation pipeline

Bio-Techne - Vertical integration

OriGene Technologies, Inc. - OEM tie-ups

LifeSpan BioSciences, Inc - Local manufacturing

Abbexa - Premium pricing

Key cd48 antibody Companies14 items

Sino Biological, Inc.

Cell Signaling Technology, Inc.

Bio-Techne

OriGene Technologies, Inc.

LifeSpan BioSciences, Inc

Abbexa

MyBiosource, Inc.

Biorbyt

Creative Biolabs

GeneTex

Arigo Biolaboratories Corp.

Abcam

RayBiotech, Inc.

Assay Genie

Market Ecosystem

The cd48 antibody ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, suppliers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of cd48 antibodies, which are used in various research and therapeutic applications. The ecosystem boundaries are defined by the interactions between these participants, influencing how value flows through the cd48 antibody ecosystem.

Raw material suppliers — providing essential reagents

Technology providers — developing antibody technologies

OEMs / manufacturers — producing cd48 antibodies

Distributors / channel partners — delivering products to end users

End users / buyers — utilizing cd48 antibodies in research and therapy

Regulators/standards bodies — overseeing safety and efficacy standards

Data/analytics providers — offering insights on market trends and applications

The flow of value through the cd48 antibody ecosystem is influenced by control points, such as regulatory approvals and standards, which can create bottlenecks and impact adoption. Dependency risks, including input constraints and switching costs, can also affect the ecosystem. Furthermore, partnerships and interoperability requirements between participants can either facilitate or hinder the exchange of value. As the cd48 antibody ecosystem differs by region, with varying levels of infrastructure and expertise, understanding these nuances is essential for navigating the complex value chain analysis of this market.

Recent Industry Insights

The cd48 antibody industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have focused on enhancing research and development capabilities, driving innovation in the field. Notable mergers and acquisitions have also led to increased consolidation, resulting in a more streamlined market landscape. Furthermore, several product and technology launches have expanded the range of available cd48 antibody products, catering to diverse research and therapeutic needs. Regulatory changes have emphasized the importance of stringent quality control measures, ensuring the highest standards of product safety and efficacy.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the cd48 antibody market. The market attractiveness is moderate, driven by increasing research activities and growing demand for targeted therapies. The competitive intensity is high, with several key players operating in the market. The long-term cd48 antibody market outlook is promising, with opportunities for innovation and growth. However, the demand-supply balance is a concern, with potential risks of supply chain disruptions and regulatory challenges. Key risk factors include intense competition, high research and development costs, and uncertain regulatory environments.

12 items

1. Executive Summary

2. cd48 antibody Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global cd48 antibody Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global cd48 antibody Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global cd48 antibody Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global cd48 antibody Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global cd48 antibody Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global cd48 antibody Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global cd48 antibody Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global cd48 antibody Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global cd48 antibody Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global cd48 antibody Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global cd48 antibody Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global cd48 antibody Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global cd48 antibody Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global cd48 antibody Market Competition by Key Manufacturers

9.1. Global cd48 antibody Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global cd48 antibody: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Sino Biological, Inc.

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Cell Signaling Technology, Inc.

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Bio-Techne

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. OriGene Technologies, Inc.

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. LifeSpan BioSciences, Inc

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Abbexa

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. MyBiosource, Inc.

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Biorbyt

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Creative Biolabs

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. GeneTex

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Arigo Biolaboratories Corp.

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Abcam

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. RayBiotech, Inc.

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Assay Genie

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global cd48 antibody Market

Figure 4: Global cd48 antibody Market: Drivers

Figure 5: Global cd48 antibody Market: Challenges

Figure 6: Global cd48 antibody Market: Trends

Figure 7: Global cd48 antibody Market: Opportunity

Figure 8: Global cd48 antibody Market: Restraint

Figure 9: Global cd48 antibody Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global cd48 antibody Market Value (USD Million) By Region

Figure 19: Global cd48 antibody Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global cd48 antibody Market Value (USD Million) By Region

Figure 27: Global cd48 antibody Market Share (%) By: Regions (2032)

Figure 28: Global cd48 antibody Market Volume (K) By Region

Figure 29: Global cd48 antibody Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global cd48 antibody Market Value (USD Million) By Region

Figure 37: Global cd48 antibody Market Share (%) By: Regions (2032)

Figure 38: Global cd48 antibody Market Volume (K) By Region

Figure 39: Global cd48 antibody Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

123 items

Table 1: Market Segmentation Analysis

Table 2: Global cd48 antibody Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global cd48 antibody Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global cd48 antibody Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global cd48 antibody Market Value (USD Million) By Region

Table 14: Global cd48 antibody Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global cd48 antibody Market Volume (K) By Region

Table 31: Global cd48 antibody Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global cd48 antibody Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global cd48 antibody Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global cd48 antibody Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Sino Biological, Inc. Basic Information And Sales Area

Table 52: Sino Biological, Inc.. Products Portfolio

Table 53: Cell Signaling Technology, Inc. Basic Information And Sales Area

Table 54: Cell Signaling Technology, Inc.. Products Portfolio

Table 55: Bio-Techne Basic Information And Sales Area

Table 56: Bio-Techne. Products Portfolio

Table 57: OriGene Technologies, Inc. Basic Information And Sales Area

Table 58: OriGene Technologies, Inc.. Products Portfolio

Table 59: LifeSpan BioSciences, Inc Basic Information And Sales Area

Table 60: LifeSpan BioSciences, Inc. Products Portfolio

Table 61: Abbexa Basic Information And Sales Area

Table 62: Abbexa. Products Portfolio

Table 63: MyBiosource, Inc. Basic Information And Sales Area

Table 64: MyBiosource, Inc.. Products Portfolio

Table 65: Biorbyt Basic Information And Sales Area

Table 66: Biorbyt. Products Portfolio

Table 67: Creative Biolabs Basic Information And Sales Area

Table 68: Creative Biolabs. Products Portfolio

Table 69: GeneTex Basic Information And Sales Area

Table 70: GeneTex. Products Portfolio

Table 71: Arigo Biolaboratories Corp. Basic Information And Sales Area

Table 72: Arigo Biolaboratories Corp.. Products Portfolio

Table 73: Abcam Basic Information And Sales Area

Table 74: Abcam. Products Portfolio

Table 75: RayBiotech, Inc. Basic Information And Sales Area

Table 76: RayBiotech, Inc.. Products Portfolio

Table 77: Assay Genie Basic Information And Sales Area

Table 78: Assay Genie. Products Portfolio

Table 79: Global Market Value (USD Million) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global Market Value (USD Million) (2025-2032) By Types

Table 82: Global Market Share (%) By Types (2032)

Table 83: Global Market Volume (K) (2025-2032) By Application

Table 84: Global Market Share (%) By Application (2032)

Table 85: Global Market Volume (K) (2025-2032) By Types

Table 86: Global Market Share (%) By Types (2032)

Table 87: Global cd48 antibody Market Value (USD Million) By Region

Table 88: Global cd48 antibody Market Share (%) By Region (2025-2032)

Table 89: North America Market Value (USD Million) (2025-2032) By Country

Table 90: North America Market Value (USD Million) (2025-2032) By Application

Table 91: North America Market Value (USD Million) (2025-2032) By Types

Table 92: Europe Market Value (USD Million) (2025-2032) By Country

Table 93: Europe Market Value (USD Million) (2025-2032) By Application

Table 94: Europe Market Value (USD Million) (2025-2032) By Types

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 96: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 98: South America Market Value (USD Million) (2025-2032) By Country

Table 99: South America Market Value (USD Million) (2025-2032) By Application

Table 100: South America Market Value (USD Million) (2025-2032) By Types

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 102: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 104: Global cd48 antibody Market Volume (K) By Region

Table 105: Global cd48 antibody Market Share (%) By Region (2025-2032)

Table 106: North America Market Volume (K) (2025-2032) By Country

Table 107: North America Market Volume (K) (2025-2032) By Application

Table 108: North America Market Volume (K) (2025-2032) By Types

Table 109: Europe Market Volume (K) (2025-2032) By Country

Table 110: Europe Market Volume (K) (2025-2032) By Application

Table 111: Europe Market Volume (K) (2025-2032) By Types

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 113: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 115: South America Market Volume (K) (2025-2032) By Country

Table 116: South America Market Volume (K) (2025-2032) By Application

Table 117: South America Market Volume (K) (2025-2032) By Types

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 119: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 121: Research Programs/Design For This Report

Table 122: Key Data Information From Secondary Sources

Table 123: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

cd48 antibody Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	220.00 million
Revenue forecast in 2033	444.84 million
Growth rate	CAGR of 9.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sino Biological, Inc.; Cell Signaling Technology, Inc.; Bio-Techne; OriGene Technologies, Inc.; LifeSpan BioSciences, Inc; Abbexa; MyBiosource, Inc.; Biorbyt; Creative Biolabs; GeneTex; Arigo Biolaboratories Corp.; Abcam; RayBiotech, Inc.; Assay Genie
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options